AllianceBernstein’s Arcus Biosciences RCUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.74M | Buy |
126,975
+2,890
| +2% | +$71.4K | ﹤0.01% | 1861 |
|
|
2026
Q1 | $2.96M | Sell |
124,085
-9,013
| -7% | -$195K | ﹤0.01% | 1789 |
|
|
2025
Q4 | $3.17M | Sell |
133,098
-4,091
| -3% | -$83.5K | ﹤0.01% | 1756 |
|
|
2025
Q3 | $1.87M | Buy |
137,189
+15,750
| +13% | +$164K | ﹤0.01% | 2042 |
|
|
2025
Q2 | $989K | Buy |
121,439
+8,179
| +7% | +$69.9K | ﹤0.01% | 2294 |
|
|
2025
Q1 | $889K | Buy |
113,260
+40,750
| +56% | +$472K | ﹤0.01% | 2302 |
|
|
2024
Q4 | $1.08M | Sell |
72,510
-1,228,444
| -94% | -$20.1M | ﹤0.01% | 2298 |
|
|
2024
Q3 | $19.9M | Buy |
1,300,954
+40,172
| +3% | +$633K | 0.01% | 916 |
|
|
2024
Q2 | $19.2M | Buy |
1,260,782
+109,654
| +10% | +$1.77M | 0.01% | 902 |
|
|
2024
Q1 | $21.7M | Sell |
1,151,128
-34,816
| -3% | -$602K | 0.01% | 846 |
|
|
2023
Q4 | $22.7M | Buy |
1,185,944
+251,361
| +27% | +$4.02M | 0.01% | 837 |
|
|
2023
Q3 | $16.8M | Sell |
934,583
-105,848
| -10% | -$2.13M | 0.01% | 907 |
|
|
2023
Q2 | $21.1M | Buy |
1,040,431
+22,502
| +2% | +$428K | 0.01% | 840 |
|
|
2023
Q1 | $18.6M | Buy |
1,017,929
+132,798
| +15% | +$2.54M | 0.01% | 870 |
|
|
2022
Q4 | $18.3M | Sell |
885,131
-151,466
| -15% | -$4.17M | 0.01% | 863 |
|
|
2022
Q3 | $27.1M | Sell |
1,036,597
-91,901
| -8% | -$2.43M | 0.01% | 737 |
|
|
2022
Q2 | $28.6M | Buy |
1,128,498
+58,555
| +5% | +$1.43M | 0.01% | 745 |
|
|
2022
Q1 | $33.8M | Buy |
1,069,943
+1,025,643
| +2,315% | +$34.4M | 0.01% | 727 |
|
|
2021
Q4 | $1.79M | Sell |
44,300
-7,200
| -14% | -$279K | ﹤0.01% | 2203 |
|
|
2021
Q3 | $1.8M | Hold |
51,500
| – | – | ﹤0.01% | 2228 |
|
|
2021
Q2 | $1.41M | Buy |
51,500
+6,500
| +14% | +$186K | ﹤0.01% | 2376 |
|
|
2021
Q1 | $1.26M | Buy |
45,000
+1,100
| +3% | +$38.3K | ﹤0.01% | 2313 |
|
|
2020
Q4 | $1.14M | Hold |
43,900
| – | – | ﹤0.01% | 2240 |
|
|
2020
Q3 | $752K | Sell |
43,900
-6,600
| -13% | -$147K | ﹤0.01% | 2311 |
|
|
2020
Q2 | $1.25M | Buy |
50,500
+11,800
| +30% | +$318K | ﹤0.01% | 2097 |
|
|
2020
Q1 | $537K | Buy |
38,700
+8,100
| +26% | +$101K | ﹤0.01% | 2316 |
|
|
2019
Q4 | $309K | Buy |
30,600
+2,900
| +10% | +$24.4K | ﹤0.01% | 2765 |
|
|
2019
Q3 | $252K | Sell |
27,700
-600
| -2% | -$4.82K | ﹤0.01% | 2860 |
|
|
2019
Q2 | $225K | Buy |
28,300
+6,600
| +30% | +$66.1K | ﹤0.01% | 2927 |
|
|
2019
Q1 | $271K | Buy |
21,700
+10,900
| +101% | +$118K | ﹤0.01% | 2800 |
|
|
2018
Q4 | $116K | Buy |
+10,800
| New | +$126K | ﹤0.01% | 2983 |
|
Other funds holding RCUS
GS
SCM
WP
AllianceBernstein's RCUS Position: Q2 2026 in Review
AllianceBernstein increased its Arcus Biosciences (RCUS) stake by 2.3% in Q2 2026, buying an estimated $71.4K and bringing the position to 126,975 shares worth $2.74M. The position accounts for ﹤0.01% of the portfolio, ranked #1861.
AllianceBernstein first reported a position in RCUS in Q4 2018 and has held it in 31 quarters since. The position peaked at $33.8M in Q1 2022. 232 funds tracked by Wall St. Rank hold RCUS as of Q2 2026.
- AllianceBernstein held 126,975 shares of Arcus Biosciences worth $2.74M as of Q2 2026.
- AllianceBernstein bought 2,890 Arcus Biosciences shares in Q2 2026, an estimated $71.4K.
- Arcus Biosciences made up ﹤0.01% of AllianceBernstein's portfolio in Q2 2026, its #1861 holding.
- AllianceBernstein first reported a position in Arcus Biosciences in Q4 2018 and has held it in 31 quarters since.
- AllianceBernstein's Arcus Biosciences position peaked at $33.8M in Q1 2022.
- 232 funds tracked by Wall St. Rank held Arcus Biosciences as of Q2 2026.
Based on AllianceBernstein's 13F filing for Q2 2026, filed 14 Aug 2026.